awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38812588-6C0A4685-A860-4682-9AA6-90F0B461B316
Q38812588-6C0A4685-A860-4682-9AA6-90F0B461B316
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38812588-6C0A4685-A860-4682-9AA6-90F0B461B316
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).
P2860
Q38812588-6C0A4685-A860-4682-9AA6-90F0B461B316
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38812588-6C0A4685-A860-4682-9AA6-90F0B461B316
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a6e2b8d2a35bc1075f66046f5dff981bcc7da26f
P2860
The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis.